REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,982,000 | -28.9% | 19,700 | 0.0% | 0.00% | -42.9% |
Q2 2021 | $2,788,000 | -47.6% | 19,700 | -46.5% | 0.01% | -73.1% |
Q1 2020 | $5,317,000 | +294.1% | 36,833 | +458.1% | 0.03% | +420.0% |
Q4 2019 | $1,349,000 | +16762.5% | 6,600 | +7233.3% | 0.01% | – |
Q1 2019 | $8,000 | – | 90 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $94,902,000 | 15.92% |
Opaleye Management Inc. | 407,002 | $13,333,000 | 4.14% |
Ikarian Capital, LLC | 649,600 | $21,281,000 | 2.80% |
AWH Capital, L.P. | 150,000 | $2,459,457 | 2.54% |
Boxer Capital, LLC | 1,239,000 | $40,590,000 | 2.09% |
EcoR1 Capital, LLC | 1,975,611 | $64,721,000 | 2.02% |
Camber Capital Management LP | 1,500,000 | $49,140,000 | 1.78% |
MPM BioImpact LLC | 180,000 | $5,897,000 | 1.58% |
Sofinnova Investments, Inc. | 602,545 | $19,739,000 | 1.50% |
KRS Capital Management, LLC | 28,141 | $921,000 | 1.00% |